View the complete Missouri Regional Life Sciences Summit supplement from the Kansas City and St. Louis Business Journals. Click here to view.
Jamal Ibdah, senior associate dean for research and director, MU Institute for Clinical and Translational Science, University of Missouri-Columbia: "Translational Medicine: From Discovery To Health": Translational Medicine: From Discovery To Health
Sitta Sittampalam, professor, department of pharmacology, toxicology and therapeutics, University of Kansas Medical Center.
The Institute for Advancing Medical Innovations: Stepping into the future of drug discovery, delivery and biomedical engineering: Inspired by the opportunity to grow educational and entrepreneurial capacity, the Institute for Advancing Medical Innovation (IAMI) was established upon the belief that: ideas are translated to innovation to improve health. The Institute will focus on education and research that advances medical innovations. The result will ultimately accelerate the number and quality of new drugs, medical devices and drug–medical device combinations flowing from the investigators bench to the patient’s bedside. Guided by an advisory board of independent experts and staffed by experienced drug development and medical device leaders, the Institute is designed to create an unprecedented collaboration of resources and processes to support the following key objectives:
• Advance new, novel medical innovations for the diagnosis, treatment, prevention and control of human and animal disease;
• Create a culture of multi-disciplinary, multi-organizational collaboration focused on advancing medical innovations from discovery to commercialization;
• Conduct clinical proof of concept trials on new, novel medical innovations; and
• Prepare graduate and postdoctoral students for careers in development and commercialization of medical innovations.
The Institute was created with a gift of $8.1 million from the Kauffman Foundation with a challenge match of $8 million from KU Endowment.